Pharmacokinetics of remdesivir in a COVID-19 patient with end-stage renal disease on intermittent haemodialysis

被引：27

作者：

Soergel, Fritz ^{[1
,2
]}

Malin, Jakob J. ^{[3
,4
,5
]}

Hagmann, Henning ^{[4
,6
]}

Kinzig, Martina ^{[1
]}

Bilal, Muhammad ^{[7
,8
]}

Eichenauer, Dennis A. ^{[9
]}

Scherf-Clavel, Oliver ^{[1
,10
]}

Simonis, Alexander ^{[3
,4
]}

El Tabei, Lobna ^{[7
,8
]}

Fuhr, Uwe ^{[7
,8
]}

Rybniker, Jan ^{[3
,4
,5
]}

机构：

[1] IBMP Inst Biomed & Pharmaceut Res, Paul Ehrlich Str 19, D-90562 Nurnberg, Germany

[2] Univ Duisburg Essen, West German Heart & Vasc Ctr, Inst Pharmacol, Essen, Germany

[3] Univ Cologne, Div Infect Dis, Dept Internal Med 1, Cologne, Germany

[4] Univ Cologne, Ctr Mol Med Cologne CMMC, Fac Med, Cologne, Germany

[5] German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Cologne, Germany

[6] Univ Hosp Cologne, Dept Internal Med 2, Cologne, Germany

[7] Univ Cologne, Fac Med, Cologne, Germany

[8] Univ Cologne, Univ Hosp Cologne, Ctr Pharmacol, Dept Pharmacol 1, Cologne, Germany

[9] Univ Cologne, Ctr Integrated Oncol Aachen Bonn Cologne Dusseldo, Dept Internal Med 1, Intens Care Program, Cologne, Germany

[10] Univ Wurzburg, Inst Pharm & Food Chem, Wurzburg, Germany

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2021年 / 76卷 / 03期

关键词：

D O I：

10.1093/jac/dkaa500

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：825 / 827

页数：4

共 50 条

[21] Investigating the utility of COVID-19 antibody testing in end-stage renal disease patients receiving haemodialysis: a cohort study in the United Kingdom
Olivia Wickens
Rajkumar Chinnadurai
Fahmida Mannan
Frida Svendsen
Mirza Yasar Baig
Chukwuma Chukwu
Ibrahim Ali
Christina Summersgill
Dawn Evans
Berckley V. Antoine
Julie Oxton
Nathan Mairs
Emma Flanagan
Robert Oliver
Philip A. Kalra
Dimitrios Poulikakos
BMC Nephrology, 22
[22] Investigating the utility of COVID-19 antibody testing in end-stage renal disease patients receiving haemodialysis: a cohort study in the United Kingdom
Wickens, Olivia
Chinnadurai, Rajkumar
Mannan, Fahmida
Svendsen, Frida
Baig, Mirza Yasar
Chukwu, Chukwuma
Ali, Ibrahim
Summersgill, Christina
Evans, Dawn
Antoine, Berckley V.
Oxton, Julie
Mairs, Nathan
Flanagan, Emma
Oliver, Robert
Kalra, Philip A.
Poulikakos, Dimitrios
BMC NEPHROLOGY, 2021, 22 (01)
[23] Stone, Haemodialysis, End-stage Renal Disease, Carotid Atherosclerosis
Patil, Santosh
Sinha, Nidhi
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2013, 7 (06) : 1228 - 1231
[24] Removal of clodronate by haemodialysis in end-stage renal disease patients
Beigel, AE
Rienhoff, E
Olbricht, CJ
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (12) : 2266 - 2268
[25] Quality of life of patients on haemodialysis for end-stage renal disease
Cleary, J
Drennan, J
JOURNAL OF ADVANCED NURSING, 2005, 51 (06) : 577 - 586
[26] Carbimazole therapy in the setting of end-stage renal disease and haemodialysis
Varughese, George I.
Tahrani, Abd A.
Smith, Jen L.
Clayton, Richard N.
Hanna, Fahmy W.
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (08) : 2318 - 2319
[27] INFLAMMATORY MARKERS IN END-STAGE RENAL DISEASE PATIENTS ON HAEMODIALYSIS
Abdel-Messeih, Phebe Lotfy
Alkady, Manal Mohamed
Nosseir, Neveen Mostafa
Tawfik, Mohamed Said
JOURNAL OF MEDICAL BIOCHEMISTRY, 2020, 39 (04) : 481 - 487
[28] Persistence of coronavirus disease 2019 (COVID-19) in patients with end-stage renal disease; an unrecognized phenomenon?
Onuigbo, Macaulay Amechi Chukwukadibia
JOURNAL OF RENAL INJURY PREVENTION, 2021, 10 (01): : 1 - 3
[29] Pharmacokinetics of rosiglitazone in patients with end-stage renal disease
Thompson-Culkin, K
Zussman, B
Miller, AK
Freed, MI
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2002, 30 (04) : 391 - 399
[30] Nefopam Pharmacokinetics in Patients with End-Stage Renal Disease
Mimoz, Olivier
Chauvet, Stephane
Gregoire, Nicolas
Marchand, Sandrine
Le Guern, Marie-Emmanuelle
Saleh, Ashraf
Couet, William
Debaene, Bertrand
Levy, Rene H.
ANESTHESIA AND ANALGESIA, 2010, 111 (05): : 1146 - 1153

← 1 2 3 4 5 →